Perrigo Co PLC (PRGO): Net Income
-$1.43B
Year ended 2025-12-31
-$1.73B
Trailing 12 months to 2026-06-27
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.43B | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$171.80M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$12.70M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$140.60M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$68.90M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$162.60M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $146.10M | +11.5% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $131.00M | +9.5% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $119.60M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$4.01B | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2015-06-27 and 2016-12-31. | |||
| 2015-06-27 | $136.10M | -41.5% | 2018-03-01, From 2014-06-29 |
| 2014-06-28 | $232.80M | n/c | 2017-05-22, From 2013-06-30 |
| 2013-06-29 | $441.90M | +10.0% | 2015-08-13, From 2012-07-01 |
| 2012-06-30 | $401.60M | n/a | 2014-08-14, From 2011-06-26 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.43B | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$356.15M | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$232.00M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $313.75M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $286.93M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $348.90M | -18.3% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.33B | +11.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $72.06M | n/m |
| Organon & Co. (OGN) | 2025-12-31 | $187.00M | -78.4% |
Compare PRGO, JAZZ, ELAN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗